DAFNA Capital Management’s HOOKIPA Pharma HOOK Stock Holding History

DAFNA Capital Management’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-32,044	Closed	-$747K	–	96
2021 Q4	$747K	Sell	32,044 -168	-0.5%	-$6.75K	0.19%	73
2021 Q3	$1.9M	Hold	32,212	–	–	0.5%	48
2021 Q2	$2.95M	Sell	32,212 -2,134	-6%	-$285K	0.62%	40
2021 Q1	$4.62M	Buy	34,346 +9,346	+37%	+$1.13M	1.1%	28
2020 Q4	$2.77M	Buy	25,000 +22,794	+1,033%	+$2.46M	0.83%	29
2020 Q3	$209K	Sell	2,206 -5,806	-72%	-$592K	0.07%	77
2020 Q2	$931K	Buy	+8,012	New	+$781K	0.27%	59

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DAFNA Capital Management's HOOK Position: Q1 2022 in Review

DAFNA Capital Management sold out of HOOKIPA Pharma (HOOK) in Q1 2022, closing a stake of 32,044 shares — an estimated $747K sold.

DAFNA Capital Management first reported a position in HOOK in Q2 2020 and held it in 7 quarters. The position peaked at $4.62M in Q1 2021. 74 funds tracked by Wall St. Rank hold HOOK as of Q1 2022.

DAFNA Capital Management reported no remaining HOOKIPA Pharma position as of Q1 2022 after selling out during the quarter.
DAFNA Capital Management sold 32,044 HOOKIPA Pharma shares in Q1 2022, an estimated $747K.
DAFNA Capital Management first reported a position in HOOKIPA Pharma in Q2 2020 and held it in 7 quarters.
DAFNA Capital Management's HOOKIPA Pharma position peaked at $4.62M in Q1 2021.
74 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2022.

Based on DAFNA Capital Management's 13F filing for Q1 2022, filed 16 May 2022.